Analyzing eq-5d in phase 3 clinical trials of type 2 diabetes mellitus (t2dm)- is mean change capturing patient impact?
May 1, 2015, 00:00
10.1016/j.jval.2015.03.385
https://www.valueinhealthjournal.com/article/S1098-3015(15)00442-8/fulltext
Title :
Analyzing eq-5d in phase 3 clinical trials of type 2 diabetes mellitus (t2dm)- is mean change capturing patient impact?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00442-8&doi=10.1016/j.jval.2015.03.385
First page :
A66
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
1487